Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NuVasive completes IPO (initial public offering) for $71.5million:

This article was originally published in Clinica

Executive Summary

NuVasive, the San Diego, California-based developer of minimally invasive spine surgery products, has priced its IPO at $11 per share. The company is offering 6.5 million shares, valuing the offering at $71.5m before over-allotments. The original price range was expected to be $11-13 per share. The company recently amended its SEC registration document to raise the upper limit of the offering including over-allotments to $97.1m from $92m. The company had sales of $22.7m in 2003, but is still loss-making.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel